de KruifM, SpijkerAT, MolendijkML. Depression during the perimenopause: A meta-analysis. J Affect Disord, 2016; 206:174–180.
2.
FreemanEW, SammelMD, BoormanDW, ZhangR. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry, 2014; 71:36–43.
3.
FreemanEW, SammelMD, LinH. Temporal associations of hot flashes and depression in the transition to menopause. Menopause, 2009; 16:728–734.
4.
MishraGD, KuhD. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ, 2012; 344:e402.
5.
GeorgakisMK, ThomopoulosTP, DiamantarasAA, et al.Association of age at menopause and duration of reproductive period with depression after menopause: A systematic review and meta-analysis. JAMA Psychiatry, 2016; 73:139–149.
6.
RyanJ, BurgerHG, SzoekeC, et al.A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Menopause, 2009; 16:509–517.
7.
FreemanEW, SammelMD, LinH, NelsonDB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry, 2006; 63:375–382.
8.
FreemanEW, SammelMD, LinH, et al.Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol, 2007; 110(2 Pt 1):230–240.
9.
WhedonJ, kizhakkeVeettilA, RugoN, KiefferK. Bioidentical estrogen for menopausal depressive symptoms: A systematic review and meta-analysis. J Womens Health (Larchmt), 2017; 26:18–28.
10.
SlaterC, HodisH, MackW, ShoupeD, PaulsonR, StanczykF. Markedly elevated levels of estrone sulfate after long term oral, but not transdermal, administration of estradiol in postmenopausal women. Menopause, 2001; 8:200–203.
11.
NachtigallL, RajuU, BanerjeeS, WanL, LevitzM. Serum estradiol binding profiles in postmenopausal women undergoing three common estrogen replacement therapies. Menopause, 2000; 7:243–250.
12.
RaiszLG, WiitaB, ArtisA, et al.Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resoprtion in postmenopausal women. J Clin Endocrinol Metab, 1995; 81:37–43.
13.
DunnJF, NisulaBC, RodboardD. Transport of steroid hormones. Binding of 21 endogenous steroids to both testosterone-binding globulin and cortico-steroid-binding globulin in human plasma. J Clin Endocrinol Metab, 1981; 53:58.
14.
DavisSR, JaneF. Drugs for the treatment of menopausal symptoms. Expert Opin Pharmacother, 2010; 11:1329–1341.
15.
MorrisonMF, KallanMJ, Ten HaveT, KatzI, TweedyK, BattistiniM. Lack of efficacy of estradiol for depression in postmenopausal women: A randomized, controlled trial. Biol Psychiatry, 2004; 55:406–412.
16.
SaletuB, BrandstatterN, MetkaM, et al.Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology, 1995; 122:321–329.
17.
SoaresCN, AlmeidaOP, JoffeH, CohenLS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry, 2001; 58:529–534.
18.
DermanRJ, DawoodMY, StoneS. Quality of life during sequential hormone replacement therapy—A placebo-controlled study. Int J Fertil Menopausal Stud, 1995; 40:73–78.
19.
ThomsonJ, OswaldI. Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. Br Med J, 1977; 2:1317–1319.
20.
PrattL, BrodyDJ, GuQ. antidepressant use in persons aged 12 and over: United States, 2005–2008. National Centre for Health Statistics, 2011;NCHS Data Brief No. 76, 2011.
